Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Other Non Operating Income (2019 - 2025)

Bioadaptives' Other Non Operating Income history spans 7 years, with the latest figure at $32100.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at $32100.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $307117.0 (up 216.94% YoY), and the annual figure for FY2025 was $133800.0, changed.
  • Other Non Operating Income for Q4 2025 was $32100.0 at Bioadaptives, down from $101700.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $138337.0 in Q3 2021 to a low of -$316056.0 in Q4 2023.
  • The 5-year median for Other Non Operating Income is -$5067.0 (2022), against an average of -$40055.9.
  • The sharpest move saw Other Non Operating Income plummeted 604.66% in 2023, then surged 234.72% in 2025.
  • Year by year, Other Non Operating Income stood at $94201.0 in 2021, then tumbled by 105.38% to -$5067.0 in 2022, then tumbled by 6137.54% to -$316056.0 in 2023, then soared by 126.67% to $84292.0 in 2024, then plummeted by 61.92% to $32100.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $32100.0, $101700.0, and $121305.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.